|

Zee Live News News, World's No.1 News Portal

LIVE NEWS
‘Avengers: Doomsday’ first look set for CinemaCon debut amid star-studded showcase of ‘Spider-Man’, ‘The Odyssey’ and more | – The Times of IndiaTitle: Artemis II astronauts journey back to Earth after Moon missionMaharashtra govt, AIIMS Nagpur ink MoU to tackle childhood NCDs$950 million bet before Trump’s announcement? US senators urge probe into ‘unusual’ oil trading – The Times of IndiaDeadspin | Braves tally six runs in sixth to outslug Guardians‘Avengers: Doomsday’ first look set for CinemaCon debut amid star-studded showcase of ‘Spider-Man’, ‘The Odyssey’ and more | – The Times of IndiaTitle: Artemis II astronauts journey back to Earth after Moon missionMaharashtra govt, AIIMS Nagpur ink MoU to tackle childhood NCDs$950 million bet before Trump’s announcement? US senators urge probe into ‘unusual’ oil trading – The Times of IndiaDeadspin | Braves tally six runs in sixth to outslug Guardians

Novo

Novo Nordisk cuts starting price of Ozempic by 36% and Wegovy by 48%

Novo Nordisk cuts starting price of Ozempic by 36% and Wegovy by 48%

admin_zeelivenews

Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up | Company Business News

Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up | Company Business News

admin_zeelivenews

Novo Nordisk A/S: Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes

Novo Nordisk A/S: Awiqli® approved in the US, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes

admin_zeelivenews

Novo Nordisk sues Dr. Reddy’s over Ozempic trademark | Company Business News

Novo Nordisk sues Dr. Reddy’s over Ozempic trademark | Company Business News

admin_zeelivenews

Generic versions of Novo Nordisk’s semaglutide begin to flow, priced 50-80% lower than the innovator

Generic versions of Novo Nordisk’s semaglutide begin to flow, priced 50-80% lower than the innovator

admin_zeelivenews

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

admin_zeelivenews

Ozempic’s drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they? | Company Business News

Ozempic’s drug maker, Novo Nordisk, receives FDA warning letter over unreported side effects: What are they? | Company Business News

admin_zeelivenews

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

admin_zeelivenews

Novo and Hims end feud, will sell obesity drugs together

Novo and Hims end feud, will sell obesity drugs together

admin_zeelivenews

Novo Nordisk shares drop 15% after poor trial results for new obesity drug

Novo Nordisk shares drop 15% after poor trial results for new obesity drug

admin_zeelivenews

Plugin developed by ProSEOBlogger
Facebook
Telegram
Telegram
Plugin developed by ProSEOBlogger. Get free Ypl themes.
Plugin developed by ProSEOBlogger. Get free gpl themes